Literature DB >> 22469125

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).

Laura Biganzoli1, Hans Wildiers, Catherine Oakman, Lorenza Marotti, Sibylle Loibl, Ian Kunkler, Malcolm Reed, Stefano Ciatto, Adri C Voogd, Etienne Brain, Bruno Cutuli, Catherine Terret, Margot Gosney, Matti Aapro, Riccardo Audisio.   

Abstract

As the mean age of the global population increases, breast cancer in older individuals will be increasingly encountered in clinical practice. Management decisions should not be based on age alone. Establishing recommendations for management of older individuals with breast cancer is challenging because of very limited level 1 evidence in this heterogeneous population. In 2007, the International Society of Geriatric Oncology (SIOG) created a task force to provide evidence-based recommendations for the management of breast cancer in elderly individuals. In 2010, a multidisciplinary SIOG and European Society of Breast Cancer Specialists (EUSOMA) task force gathered to expand and update the 2007 recommendations. The recommendations were expanded to include geriatric assessment, competing causes of mortality, ductal carcinoma in situ, drug safety and compliance, patient preferences, barriers to treatment, and male breast cancer. Recommendations were updated for screening, primary endocrine therapy, surgery, radiotherapy, neoadjuvant and adjuvant systemic therapy, and metastatic breast cancer.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22469125     DOI: 10.1016/S1470-2045(11)70383-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  151 in total

1.  AMP hydrolysis reduction in blood plasma of breast cancer elderly patients after different treatments.

Authors:  Fernanda Valente Gheler; Angélica Regina Cappellari; Daiana Renck; Julia Brandt de Souza; Renan Oliveira de Melo; Barbara Zanesco Moehlecke; Carolina Aiko Moriguchi; Paula Engroff; Ana Paula Franco Lambert; Liliana Rockenbach; Fernanda Bueno Morrone
Journal:  Mol Cell Biochem       Date:  2021-06-05       Impact factor: 3.396

2.  Radiation oncologists' view on the zurich consensus.

Authors:  Rainer Souchon; Marie-Luise Sautter-Bihl; Felix Sedlmayer; Frederik Wenz; Wilfried Budach; Rolf Sauer
Journal:  Breast Care (Basel)       Date:  2013-12       Impact factor: 2.860

3.  Age Does not Matter, Biology of Both Cancer and Patient Does.

Authors:  Matti S Aapro
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

Review 4.  Present status of adjuvant chemotherapy for elderly breast cancer patients.

Authors:  Sibylle Loibl; Mattea Reinisch
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

5.  Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.

Authors:  Marloes G M Derks; Cornelis J H van de Velde; Daniele Giardiello; Caroline Seynaeve; Hein Putter; Johan W R Nortier; Luc Y Dirix; Esther Bastiaannet; Johanneke E A Portielje; Gerrit-Jan Liefers
Journal:  Oncologist       Date:  2019-01-03

Review 6.  Factors influencing adherence to cancer treatment in older adults with cancer: a systematic review.

Authors:  M T E Puts; H A Tu; A Tourangeau; D Howell; M Fitch; E Springall; S M H Alibhai
Journal:  Ann Oncol       Date:  2013-11-26       Impact factor: 32.976

7.  Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group.

Authors:  J Barinoff; A Traut; D Bauerschlag; J Bischoff; D Herr; K Lübbe; H-J Lück; N Maass; C Mundhenke; M Schmidt; K Schwedler; M Thill; J Steffen; S Loibl; G von Minckwitz
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-05       Impact factor: 2.915

8.  White-Black Differences in Cancer Incidence, Stage at Diagnosis, and Survival among Adults Aged 85 Years and Older in the United States.

Authors:  Jessica L Krok-Schoen; James L Fisher; Ryan D Baltic; Electra D Paskett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-15       Impact factor: 4.254

9.  Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.

Authors:  Diana Crivellari; Kathryn P Gray; Silvia Dellapasqua; Fabio Puglisi; Karin Ribi; Karen N Price; István Láng; Lorenzo Gianni; Simon Spazzapan; Graziella Pinotti; Jean-Marc Lüthi; Richard D Gelber; Meredith M Regan; Marco Colleoni; Monica Castiglione-Gertsch; Rudolf Maibach; Manuela Rabaglio; Alan S Coates; Aron Goldhirsch
Journal:  Breast       Date:  2013-02-28       Impact factor: 4.380

10.  "Winging It": How Older Breast Cancer Survivors Persist With Aromatase Inhibitor Treatment.

Authors:  Eden R Brauer; Patricia A Ganz; Huibrie C Pieters
Journal:  J Oncol Pract       Date:  2016-09-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.